आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

merck sharp & dohme ireland (human health) limited - hydrochlorothiazide; amiloride hydrochloride - tablet - 25 mg/2.5 milligram(s) - low-ceiling diuretics and potassium-sparing agents; hydrochlorothiazide and potassium-sparing agents

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - losartan potassium; hydrochlorothiazide - film-coated tablet - losartan and diuretics

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - losartan potassium; hydrochlorothiazide - film-coated tablet - losartan and diuretics

केन्या - अंग्रेज़ी - Pharmacy and Poisons Board

msd (pty) ltd 117 16th road, halfway house 1685, south africa - amiloride hcl and hydrochlorothiazide - tablet - 5 mg amiloride hcl and 50 mg hydrochlorothiazide - thiazides low-ceiling diuretics: plain thiazides

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - hydrochlorothiazide, quantity: 50 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate dihydrate; lactose monohydrate; maize starch; guar gum; sunset yellow fcf; pregelatinised maize starch; magnesium stearate - indicated in the treatment of patients with oedema of cardiac origin; hepatic cirrhosis with ascites; hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of excessive drop in blood pressure.

कनाडा - अंग्रेज़ी - Health Canada

altimed pharma inc. - hydrochlorothiazide; amiloride hydrochloride - tablet - 50mg; 5mg - hydrochlorothiazide 50mg; amiloride hydrochloride 5mg - potassium-sparing diuretics

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

glaxosmithkline llc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

cardinal health - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

mckesson rxpak inc - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq) - hydrochlorothiazide 25 mg - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked. dyazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. since dyazide may enhance the action of these agents, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed toxemia. edema during pregnancy may arise from pathological causes or from the physiologic and mechanical conseque

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

directrx - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), lisinopril (unii: e7199s1ywr) (lisinopril anhydrous - unii:7q3p4bs2fd) - hydrochlorothiazide 12.5 mg - - lisinopril and hydrochlorothiazide tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including lisinopril and hydrochlorothiazide. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program's joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, fro